alexa Dexamethasone adjunctive treatment for tuberculous meningitis.


Mycobacterial Diseases

Author(s): Girgis NI, Farid Z, Kilpatrick ME, Sultan Y, Mikhail IA

Abstract Share this page

Abstract During a 5-year period, 280 of 2010 patients admitted to the meningitis ward of a referral hospital in Cairo, Egypt, were clinically diagnosed as having tuberculous meningitis and were treated with either antituberculous chemotherapy and dexamethasone or antituberculous chemotherapy alone. Fatality rates and neurologic sequelae were compared for the 2 treatment groups in the 160 patients who had cerebrospinal fluid cultures positive for Mycobacterium tuberculosis. The overall mortality rate of 51\% reflects the delay in receiving appropriate therapy (79\% with symptoms for more than 2 weeks) and the severity of illness on admission (56\% in coma, 39\% drowsy). The fatality rate was significantly lower in the group receiving dexamethasone (43\% vs. 59\%, P less than 0.05), particularly in the drowsy patients (15\% vs. 40\% P less than 0.04), and in patients surviving long enough to receive at least 10 days of treatment (14\% vs. 33\%, P less than 0.02). Development of neurologic complications after initiation of therapy (4 vs. 10) and permanent sequelae (6 vs. 13) were significantly lower in the dexamethasone-treated group (P less than 0.02).
This article was published in Pediatr Infect Dis J and referenced in Mycobacterial Diseases

Relevant Expert PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version